Aurora Cannabis (TSE:ACB) has released an update.
Aurora Cannabis Inc. has received expanded cultivation and research licenses in Germany, bolstering its production and research capabilities for medical cannabis. With these licenses, Aurora will increase its product offerings to meet the growing demands of German patients and conduct trials on novel cultivars at its EU GMP-certified facility.
For further insights into TSE:ACB stock, check out TipRanks’ Stock Analysis page.
